News Articles http://www.drugdiscoveryonline.com/ Wed, 01 Jul 2009 10:37:14 GMT Cephalon, Inc. (Nasdaq: <a href="http://studio-5.financialcontent.com/prnews?Page=Quote&Ticker=CEPH"target="new">CEPH</a>) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval of NUVIGIL&reg; (armodafinil) Tablets [C-IV] for the indication of improved wakefulness in patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel http://www.drugdiscoveryonline.com/article.mvc/Cephalon-Submits-NUVIGIL-Supplemental-New-Dru-0001?atc~c=771+s=773+r=001+l=a Wed, 01 Jul 2009 10:37:14 GMT Certara, a global, translational sciences company formed by the acquisition of Pharsight Corporation by Tripos, recently announced expanded investment and presence in China and Taiwan in support of drug discovery and development efforts, and also confirmed that Tri-I Biotech, Inc. http://www.drugdiscoveryonline.com/article.mvc/Certara-Expands-Presence-In-Drug-Discovery-0001?atc~c=771+s=773+r=001+l=a Wed, 01 Jul 2009 00:00:00 GMT BioSeek, Inc., a pioneer in the application of predictive human biology to drug discovery, announced today that the United States Environmental Protection Agency (EPA) will utilize BioSeek's BioMAP Systems technology to profile the biological effects of compounds in a second phase of the agency's ToxCast program. http://www.drugdiscoveryonline.com/article.mvc/BioSeek-And-EPA-Expand-ToxCast-Contract-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 13:01:00 GMT GE Healthcare, a unit of General Electric Company, and Geron Corporation today announced that they have entered into a global exclusive license and alliance agreement to develop and commercialize cellular assay products derived from human embryonic stem cells (hESCs) for use in drug discovery, development and toxicity screening. http://www.drugdiscoveryonline.com/article.mvc/GE-Healthcare-And-Geron-Announce-Exclusive-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 11:30:00 GMT Optimata Ltd. announced recently that it has signed a collaboration agreement with Teva Pharmaceutical Industries Ltd. focused on clinical development of drug candidates for solid tumor cancers http://www.drugdiscoveryonline.com/article.mvc/Optimata-To-Collaborate-With-Teva-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 11:00:00 GMT Accelrys, Inc., a leading provider of scientific business intelligence software and services, announced the release of Discovery Studio 2.5, the most advanced computational chemistry and biology software environment for drug discovery available today http://www.drugdiscoveryonline.com/article.mvc/Accelrys-Releases-New-Modeling-And-Simulation-0002?atc~c=771+s=773+r=001+l=a Mon, 29 Jun 2009 09:47:00 GMT GenScript Inc., a world leader in bio-reagent supply and biology CRO service announced recently that it has received a $15 million venture funding for the expansion of its biology services in drug discovery and development http://www.drugdiscoveryonline.com/article.mvc/GenScript-Raises-15M-For-Drug-Discovery-And-0001?atc~c=771+s=773+r=001+l=a Fri, 26 Jun 2009 09:36:00 GMT A revolutionary new protein stabilisation technique has been developed by scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) which could lead to 30 per cent more proteins being available as potential targets for drug development - opening up exciting possibilities in drug discovery http://www.drugdiscoveryonline.com/article.mvc/New-Nanoparticles-Could-Revolutionize-0001?atc~c=771+s=773+r=001+l=a Wed, 24 Jun 2009 08:56:00 GMT Adimab, Inc., an emerging leader in the discovery of fully human antibodies, today announced the launch of a unique human antibody discovery platform based on the first fully synthetic human pre-immune IgG repertoire. http://www.drugdiscoveryonline.com/article.mvc/Adimab-Launches-Novel-Antibody-Discovery-Plat-0001?atc~c=771+s=773+r=001+l=a Tue, 16 Jun 2009 11:00:00 GMT OPKO Health, Inc. has agreed to make an investment in Cocrystal Discovery, Inc., a privately held biopharmaceutical company focusing initially on the discovery and development of novel antiviral drugs for diseases for which current therapies are not adequate http://www.drugdiscoveryonline.com/article.mvc/OPKO-Invests-In-Biotechnology-Company-0001?atc~c=771+s=773+r=001+l=a Mon, 15 Jun 2009 15:07:00 GMT New data from Phase 3 European clinical trials reinforce that Wyeth's (NYSE: <a href="http://studio-5.financialcontent.com/prnews?Page=Quote&Ticker=WYE" target="new">WYE</a>) investigational pneumococcal vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine, 13-valent [Adsorbed]), has the potential to provide coverage against the 13 most prevalent serotypes associated with pneumococcal disease (PD), the leading cause of vaccine-preventable death in children younger than five worldwide. http://www.drugdiscoveryonline.com/article.mvc/That-Wyeths-Investigational-13-valent-Vaccin-0001?atc~c=771+s=773+r=001+l=a Thu, 11 Jun 2009 13:17:27 GMT Pharmaceutical business intelligence firm Cutting Edge Information announces the launch of its latest therapeutic area study, which provides forecasts for the autoimmune market. http://www.drugdiscoveryonline.com/article.mvc/Cutting-Edge-Informations-Latest-Therapeutic-0001?atc~c=771+s=773+r=001+l=a Thu, 11 Jun 2009 07:26:00 GMT Gentronix Limited, a genotoxicity product and services provider, and Apredica, an ADME-Tox contract research laboratory, recently announced a strategic alliance to provide drug-discovery support services in the area of predictive toxicology. http://www.drugdiscoveryonline.com/article.mvc/Gentronix-and-Apredica-Ally-To-Create-0001?atc~c=771+s=773+r=001+l=a Thu, 11 Jun 2009 06:22:00 GMT Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that it has entered a collaboration and licensing agreement with Roche (SWX: ROG.VX; RO.S, OTCQX: RHHBY) to evaluate therapeutic delivery across the blood-brain barrier, ("BBB") starting with Raptor's proprietary NeuroTrans(TM) BBB transporter platform. Under terms of the agreement, Roche will fund studies of select molecules attached to Raptor's proprietary NeuroTrans(TM), a derivative of the receptor-associated protein ("RAP"). http://www.drugdiscoveryonline.com/article.mvc/Raptor-Pharmaceuticals-To-Collaborate-With-0001?atc~c=771+s=773+r=001+l=a Tue, 09 Jun 2009 13:14:00 GMT MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, today announced that a renovation and expansion of its discovery pharmacology operation in Taiwan is under way to serve the growing global demand for work performed in Asia http://www.drugdiscoveryonline.com/article.mvc/MDS-Pharma-Services-Expands-Drug-Discovery-0001?atc~c=771+s=773+r=001+l=a Mon, 08 Jun 2009 11:10:00 GMT Novocell, Inc., a stem cell engineering company, recently announced that it has received U.S. Patent No. 7,541,185 with method claims covering the use of endoderm cells derived from human embryonic stem cells (hESCs) for drug discovery http://www.drugdiscoveryonline.com/article.mvc/Novocell-Obtains-US-Patent-For-Drug-Screening-0001?atc~c=771+s=773+r=001+l=a Wed, 03 Jun 2009 12:30:00 GMT Interim results from an ongoing phase 2, randomized, placebo-controlled trial of the investigational drug TMC207 for the treatment of multidrug-resistant tuberculosis (MDR-TB) were published in the New England Journal of Medicine recently. http://www.drugdiscoveryonline.com/article.mvc/Data-On-Investigational-Drug-TMC207-For-0001?atc~c=771+s=773+r=001+l=a Wed, 03 Jun 2009 11:50:00 GMT Pharsight, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, recently announced the launch of Phoenix WinNonlin, the next generation of the company's industry-standard software tool for pharmacokinetic and pharmacodynamic (PK/PD) modeling and noncompartmental analysis http://www.drugdiscoveryonline.com/article.mvc/Pharsight-Launches-Phoenix-WinNonlin-As-0001?atc~c=771+s=773+r=001+l=a Tue, 02 Jun 2009 12:00:00 GMT Applied Biosystems, a division of Life Technologies Corporation, recently announced that scientists at bioMérieux, a world leader in the field of in vitro diagnostics, and the Institute of Analytical Sciences of the University of Lyon in France are collaborating on research to advance the discovery of biomarkers that can be used to diagnose or monitor disease http://www.drugdiscoveryonline.com/article.mvc/French-Researchers-Accelerate-Biomarker-0001?atc~c=771+s=773+r=001+l=a Tue, 02 Jun 2009 11:30:00 GMT Concert Pharmaceuticals and GlaxoSmithKline announced recently that they will collaborate to develop and commercialize deuterium-containing medicines http://www.drugdiscoveryonline.com/article.mvc/Concert-Pharmaceuticals-And-GlaxoSmithKline-0001?atc~c=771+s=773+r=001+l=a Tue, 02 Jun 2009 07:00:00 GMT